FM
JAZZ icon

Forward Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Forward Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-300
Closed -$52K – 348
2015
Q1 		$52K Hold
300
– – ﹤0.01% 343
2014
Q4 		$49K Hold
300
– – ﹤0.01% 356
2014
Q3 		$48K Buy
+300
New +$46.1K ﹤0.01% 354

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Forward Management's JAZZ Position: Q2 2015 in Review

Forward Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2015, closing a stake of 300 shares — an estimated $52K sold.

Forward Management first reported a position in JAZZ in Q3 2014 and held it in 3 quarters. The position peaked at $52K in Q1 2015. 373 funds tracked by Wall St. Rank hold JAZZ as of Q2 2015.

  • Forward Management reported no remaining Jazz Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Forward Management sold 300 Jazz Pharmaceuticals shares in Q2 2015, an estimated $52K.
  • Forward Management first reported a position in Jazz Pharmaceuticals in Q3 2014 and held it in 3 quarters.
  • Forward Management's Jazz Pharmaceuticals position peaked at $52K in Q1 2015.
  • 373 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2015.

Based on Forward Management's 13F filing for Q2 2015, filed 11 Aug 2015.